Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07124819) titled 'Dimolegin(R) (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin' on Aug. 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Avexima Diol LLC
Condition:
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Venous Thromboembolism (VTE)
Prevention
Intervention:
Drug: Sodium enoxaparin
Drug: Dimolegin
Drug: Dimolegin placebo
Recruitment Status: Not recruiting
Phase: Phas...